3 lotion companies fail to prove ‘skin whitening’ claims, fined

NEW DELHI:  Advertisements on e-commerce platforms that claim certain body lotion can whiten your skin in just minutes always sounded fictitious. What you doubted has turned out to be true. In three recent cases, companies have admitted to the Central Consumer Protection Authority (CCPA) that these were exaggerations and they resorted to such claims of “unique selling point (USP)” to just come up on e-commerce platforms.

In orders passed by the CCPA in Feb against four companies selling whitening creams and body lotion, including the three which cited USP, the consumer watchdog has recorded how the companies failed to substantiate their claims. They withdrew their advertisements from e-commerce platforms after the authority issued notices to them.

In all these cases, investigations by the Bureau of Indian Standards confirmed that the companies failed to provide any scientific validation to their claims or any proof to support their claims. It has imposed fines on these entities and instructed them not to make such unverified and unsubstantiated claims. It cautioned them of a Rs 50 lakh fine for repeat of offence.

Interestingly, in all the four cases, the companies claimed they were unaware of the law against misleading advertisements of the CCPA.

Related Posts

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory